Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.

Stephen J Schuster <a class=“affiliation-link” title=“Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States.” href=“https://pubmed.ncbi.nlm.nih.gov/38048694#full-view-affiliation-1" ref=“linksrc=author_af …